375
Views
2
CrossRef citations to date
0
Altmetric
Review

Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region

ORCID Icon, ORCID Icon, , , , , , , ORCID Icon, , & ORCID Icon show all
Pages 1-12 | Published online: 04 Jan 2022

References

  • Chan Y, Kuhn FA. An update on the classifications, diagnosis, and treatment of rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2009;17(3):204–208. doi:10.1097/MOO.0b013e32832ac393
  • Poddighe D, Brambilla I, Amelia L, et al. Pediatric rhinosinusitis and asthma. Respir Med. 2018;141:94–99. doi:10.1016/j.rmed.2018.06.016
  • Nakayama T, Yoshikawa M, Asaka D, et al. Mucosal eosinophilia and recurrence of nasal polyps -new classification of chronic rhinosinusitis. Rhinology. 2011;49:392–396. doi:10.4193/Rhino10.261
  • Slovick LJ, Hopkins C. Updates in the management of chronic rhinosinusitis. Clin Pract. 2014;11:649. doi:10.2217/cpr.14.71
  • Hussein A, Obaid A, Lotfi WT, et al. Prevalence, demographic and environmental factors of allergic fungal sinusitis among chronic sinusitis patients with nasal polyps in western Saudi Arabia. Pan Arab J Rhinol. 2019;9:26–30.
  • Bachert C, Han JK, Wagenmann M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol. 2021;147:29–36. doi:10.1016/j.jaci.2020.11.013
  • Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58:1–464. doi:10.4193/Rhin20.401
  • Passali D, Cingi C, Cambi J, et al. A survey on chronic rhinosinusitis: opinions from experts of 50 countries. Eur Arch Otorhinolaryngol. 2016;273:2097–2109. doi:10.1007/s00405-015-3880-6
  • Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003;129:S1–S32. doi:10.1053/hn.2003.v128.amhn0312811
  • Bachert C, Zhang L, Gevaert P. Current and future treatment options for adult chronic rhinosinusitis: focus on nasal polyposis. J Allergy Clin Immunol. 2015;136:1431–1440. doi:10.1016/j.jaci.2015.10.010
  • Ostovar A, Fokkens WJ, Vahdat K, et al. Epidemiology of chronic rhinosinusitis in Bushehr, southwestern region of Iran: a GA2LEN study. Rhinology. 2019;57:43–48. doi:10.4193/Rhin18.061
  • Chen S, Zhou A, Emmanuel B, et al. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis. Curr Med Res Opin. 2020;36:1897–1911. doi:10.1080/03007995.2020.1815682
  • Staniorski JC, Price CPE, Weibman AR, et al. Asthma onset pattern and patient outcomes in a chronic rhinosinusitis population. Int Forum Allergy Rhinol. 2018;8:495–503. doi:10.1002/alr.22064
  • Gandhi NA, Bennett BL, Graham NM, et al. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov. 2016;15:35–50. doi:10.1038/nrd4624
  • Khan A, Vandeplas G, Huynh TMT, et al. The Global Allergy and Asthma European Network (GALEN rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps. Rhinology. 2019;57:32–42. doi:10.4193/Rhin17.255
  • Esmaeilzadeh H, Nabavi M, Arshi S, et al. Aspirin hypersensitivity in Iranian patients with chronic rhinosinusitis and nasal polyposis: prevalence and comorbid factors. Clin Transl Allergy. 2014;4:P22. doi:10.1186/2045-7022-4-S3-P22
  • Bassiouni A, Wormald PJ. Role of frontal sinus surgery in nasal polyp recurrence. Laryngoscope. 2013;123:36–41. doi:10.1002/lary.23610
  • Stevens WW, Peters AT, Hirsch AG, et al. Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2017;5:1061–1070. doi:10.1016/j.jaip.2016.12.027
  • Stevens WW, Lee RJ, Schleimer RP, et al. Chronic rhinosinusitis pathogenesis. J Allergy Clin Immunol. 2015;136(6):1442–1453. doi:10.1016/j.jaci.2015.10.009
  • Avdeeva K, Fokkens W. Precision medicine in chronic rhinosinusitis with nasal polyps. Curr Allergy Asthma Rep. 2018;18:25. doi:10.1007/s11882-018-0776-8
  • Ryu G, Kim DW. Th2 inflammatory responses in the development of nasal polyps and chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2020;20(1):1–8. doi:10.1097/ACI.0000000000000588
  • Measures of disease severity in CRSwNP. Available from: https://www.type2inflammation.com/-/media/EMS/Conditions/Respiratory/Brands/DupixentAsthmaHCP-US/pdf/Measures-of-Disease-Severity-in-CRSwNP.pdf?la=en. Accessed February 03, 2021.
  • Zhu M, Gao X, Zhu Z, et al. The roles of nasal nitric oxide in diagnosis and endotypes of chronic rhinosinusitis with nasal polyps. J of Otolaryngol - Head & Neck Surg. 2020;49:68. doi:10.1186/s40463-020-00465-y
  • Abdalla S, Alreefy H, Hopkins C. Prevalence of sinonasal outcome test (SNOT-22) symptoms in patients undergoing surgery for chronic rhinosinusitis in the England and Wales National prospective audit. Clin Otolaryngol. 2012;37:276–282. doi:10.1111/j.1749-4486.2012.02527.x
  • Dejaco D, Riedl D, Huber A, et al. The SNOT-22 factorial structure in European patients with chronic rhinosinusitis: new clinical insights. Eur Arch Otorhinolaryngol. 2019;276:1355–1365. doi:10.1007/s00405-019-05320-z
  • Alanazy F, Dousary SA, Albosaily A, et al. Psychometric Arabic sino-nasal outcome test-22: validation and translation in chronic rhinosinusitis patients. Ann Saudi Med. 2018;38:22–27. doi:10.5144/0256-4947.2018.22
  • Soler ZM, Kohli P, Storck KA, et al. Olfactory impairment in chronic rhinosinusitis using threshold, discrimination, and identification scores. Chem Senses. 2016;41:713–719. doi:10.1093/chemse/bjw080
  • Kohli P, Naik AN, Harruff EE, et al. The prevalence of olfactory dysfunction in chronic rhinosinusitis. Laryngoscope. 2017;127:309–320. doi:10.1002/lary.26316
  • Kamrava SK, Farhadi M, Jalessi M, et al. University of Pennsylvania smell identification on Iranian population. Iran Red Crescent Med J. 2014;16:e7926. doi:10.5812/ircmj.7926
  • Kaplan A. Canadian guidelines for chronic rhinosinusitis: clinical summary. Can Fam Physician. 2013;59:1275–e534.
  • Alsaleh S, Alqahtani A, Alotaibi NH, et al. The use of biologics in chronic rhinosinusitis with polyps: Saudi otorhinolaryngology society position statement. Saudi J Otorhinolaryngol Head Neck Surg. 2020;22:93–94.
  • Patel GB, Peters AT. The role of biologics in chronic rhinosinusitis with nasal polyps. Ear Nose Throat J. 2021;100:44–47. doi:10.1177/0145561320964653
  • FDA approves first treatment for chronic rhinosinusitis with nasal polyps. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-chronic-rhinosinusitis-nasal-polyps. Accessed February 03, 2021.